Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - The Presage™ ST2 assay

Clinica Chimica Acta

Volumn 409, Issue 1-2, 2009, Pages 33-40

  Dieplinger, Benjamin ^a   Januzzi Jr , James L ^b   Steinmair, Martin ^a   Gabriel, Christian ^c   Poelz, Werner ^d   Haltmayer, Meinhard ^a   Mueller, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Red Cross Transfusion Service of Upper Austria   (Austria)

^d JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

Author keywords

Heart failure; Inflammation; Interleukin 1 receptor family; Natriuretic peptides; Pneumonia; Sepsis

Indexed keywords

INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SENSITIVITY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SOLUBILITY;

EID: 70349813786     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.08.010     Document Type: Article

References (32)

1. Iwahana H., Yanagisawa K., Ito-Kosaka A., et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem 264 (1999) 397-406
2. Arend W.P., Palmer G., and Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223 (2008) 20-38
3. Kakkar R., and Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7 (2008) 827-840
4. Hayakawa H., Hayakawa M., Kume A., and Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282 (2007) 26369-26380
5. Trajkovic V., Sweet M.J., and Xu D. T1/ST2-an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev 15 (2004) 87-95
6. Brunner M., Krenn C., Roth G., et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 30 (2004) 1468-1473
7. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N., and Lee R.T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117 (2007) 1538-1549
8. Weinberg E.O., Shimpo M., Hurwitz S., Tominaga S., Rouleau J.L., and Lee R.T. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107 (2003) 721-726
9. Shimpo M., Morrow D.A., Weinberg E.O., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109 (2004) 2186-2190
10. Januzzi Jr. J.L., Peacock W.F., Maisel A.S., et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50 (2007) 607-613
11. Mueller T., Dieplinger B., Gegenhuber A., Poelz W., Pacher R., and Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin Chem 54 (2008) 752-756
12. Rehman S.U., Mueller T., and Januzzi Jr. J.L. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52 (2008) 1458-1465
13. Sabatine M.S., Morrow D.A., Higgins L.J., et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117 (2008) 1936-1944
14. Kuroiwa K., Li H., Tago K., et al. Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma 19 (2000) 151-159
15. Levey A.S., Greene T., Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) A0828
16. Clinical and Laboratory Standards Institute. Evaluation of precision performance of clinical chemistry devices; approved guideline. CLSI document EP5-A (1999), CLSI, Wayne, PA
17. Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. CLSI document EP6-A (2003), CLSI, Wayne, PA
18. Fraser C.G., and Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27 (1989) 409-437
19. Passing H., and Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 21 (1983) 709-720
20. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
21. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98 (1998) 2282-2289
22. Niederman M.S., Mandell L.A., Anzueto A., et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163 (2001) 1730-1754
23. Burge S., and Wedzicha J.A. COPD exacerbations: definitions and classifications. Eur Respir J 21 (2003) 46S-53S
24. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
25. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
26. Wu A.H. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 152 (2006) 828-834
27. Barassi A., Pallotti F., and Melzi d'Eril G. Biological variation of procalcitonin in healthy individuals. Clin Chem 50 (2004) 1878
28. Martinez-Rumayor A., Camargo C.A., Green S.M., Baggish A.L., O'Donoghue M., and Januzzi J.L. Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease. Am J Clin Pathol 130 (2008) 578-584
29. Bajwa E.K., Januzzi J.L., Gong M.N., Thompson B.T., and Christiani D.C. Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome. Crit Care Med 36 (2008) 2322-2327
30. Bajwa E.K., Boyce P.D., Januzzi J.L., Gong M.N., Thompson B.T., and Christiani D.C. Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med 35 (2007) 2484-2490
31. Braunwald E. Biomarkers in heart failure. N Engl J Med 358 (2008) 2148-2159
32. Bartunek J., Delrue L., Van Durme F., et al. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J Am Coll Cardiol 52 (2008) 2166-2174